These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30740940)

  • 1. Dialysis membranes: A 2018 update.
    Olczyk P; Małyszczak A; Kusztal M
    Polim Med; 2018; 48(1):57-63. PubMed ID: 30740940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.
    Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W
    Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
    Kara M; Gurluler E; Cakır U
    Ren Fail; 2015; 37(8):1293-6. PubMed ID: 26399977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a polynephron dialysis membrane considering new aspects of biocompatibility.
    Martínez-Miguel P; de Sequera P; Albalate M; Medrano D; Sánchez-Villanueva R; Molina A; Sousa F; Benito J; Nuñez J; Vozmediano C; Aragoncillo I; Barril G; Rodríguez-Puyol D; Pérez-García R; López-Ongil S
    Int J Artif Organs; 2015 Jan; 38(1):45-53. PubMed ID: 25633893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic Toxins: how can we improve the removal today?].
    Teatini U; Romei Longhena G
    G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the chemical composition and specifications of haemodialysis membranes by NMR and GPC-FTIR-coupled spectroscopy.
    Gores F; Montag P; Schall C; Vienken J; Bowry SK
    Biomaterials; 2002 Aug; 23(15):3131-40. PubMed ID: 12102184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemofiltration of recombinant hirudin by different hemodialyzer membranes: implications for clinical use.
    Benz K; Nauck MA; Böhler J; Fischer KG
    Clin J Am Soc Nephrol; 2007 May; 2(3):470-6. PubMed ID: 17699453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characterization of a new polymeric membrane for use in renal replacement therapy.
    Hoenich NA; Katopodis KP
    Biomaterials; 2002 Sep; 23(18):3853-8. PubMed ID: 12164189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia Induced by Polysulfone Dialysis Membranes.
    Claudio-Gonzalez I; Ravindranathan D; Kempton CL; Bailey JL; Wall SM
    Am J Case Rep; 2021 Jul; 22():e932045. PubMed ID: 34215716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
    Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
    Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of the polyamide membranes.
    Deppisch R; Betz M; Hänsch GM; Rauterberg EW; Ritz E
    Contrib Nephrol; 1992; 96():26-46. PubMed ID: 1740049
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
    Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
    PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of a new high-flux synthetic membrane.
    Hoenich NA; Stamp S
    Am J Kidney Dis; 2000 Aug; 36(2):345-52. PubMed ID: 10922313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quo vadis dialysis membrane?
    Vienken J; Bowry S
    Artif Organs; 2002 Feb; 26(2):152-9. PubMed ID: 11879244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.
    Herič T; Vivoda T; Bogataj Š; Pajek J
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.